An SST2 agonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Paltusotine

Item No. 42041

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
3-[4-(4-amino-1-piperidinyl)-3-(3,5-difluorophenyl)-6-quinolinyl]-2-hydroxy-benzonitrile
CAS Number
2172870-89-0
Synonyms
  • CRN00808
Molecular Formula
C27H22F2N4O
Formula Weight
456.5
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
DMSO: Slightly soluble: 0.1-1 mg/ml
SMILES
N#CC1=C(O)C(C2=CC3=C(N4CCC(CC4)N)C(C5=CC(F)=CC(F)=C5)=CN=C3C=C2)=CC=C1
InChi Code
InChI=1S/C27H22F2N4O/c28-19-10-18(11-20(29)13-19)24-15-32-25-5-4-16(22-3-1-2-17(14-30)27(22)34)12-23(25)26(24)33-8-6-21(31)7-9-33/h1-5,10-13,15,21,34H,6-9,31H2
InChi Key
GHILNKWBALQPDP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $303

    Add

    10 mg

    $484

    Add

    25 mg

    $1,060

    Add

    50 mg

    $1,513

    Add
    Product Description

    Paltusotine is a nonpeptide somatostatin receptor 2 (SST2) agonist.1 It selectively inhibits cAMP production in cells expressing SST2 over cells expressing SST1, SST3, SST4, or SST5 (EC50s = 25, >1,000, >1,000, >1,000, and >1,000 nM, respectively). In vivo, paltusotine (3, 10, and 30 mg/kg) reduces growth hormone release stimulated by growth hormone-releasing hormone (GHRH) in rats. It also reduces plasma levels of insulin-like growth factor 1 (IGF-1) in beagle dogs.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Zhao, J., Wang, S., Markison, S., et al. Discovery of paltusotine (CRN00808), a potent, selective, and orally bioavailable non-peptide SST2 agonist. ACS Med. Chem. Lett. 14(1), 66-74 (2022).